related documents
- A population-based comparison of the cardiovascular protective effects of hydrochlorothiazide and chlorthalidone Conferences
- Age-related quality of life and health status outcomes of COURAGE trial patients during long-term follow-up Conferences
- Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE) Conferences
- Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE) Conferences
- Cardiac rehabilitation reduces depression in coronary artery disease patients Conferences
- Clinical outcomes in women with stable coronary artery disease randomized to optimal medical therapy with or without PCI: Pre-specified subset analysis of the COURAGE trial Conferences
- Comparison of right ventricular strain and strain rate in patients with Arrhythmogenic right ventricular cardiomyopathy, right ventricular outflow tract tachycardia, and matched controls Conferences
- Cost effectiveness of adding PCI to optimal medical therapy in patients with stable coronary artery disease: Economic outcomes from the COURAGE trial Conferences
- Diabetes mellitus is associated with increased risk of fatal and non-fatal cardiovascular events in heart failure patients with preserved ejection fraction - Findings from the Irbesartan in heart failure with preserved systolic function trial Conferences
- Dietary supplementation with sodium valproate attenuates lesion development in hyperglycemic apolipoprotein E-deficient mice Conferences
- Differential improvement in stress myocardial perfusion ischemia following percutaneous coronary intervention as compared with optimal medical therapy alone: Nuclear substudy results from the Clinical Outcomes using Revascularization and Aggressive Drug Evaluation (COURAGE) trial Conferences
- Elevated in-hospital glucose level, and not known history of diabetes mellitus, predicts 30-day mortality following acute ST-elevation myocardial infarction Conferences
- Genetic variants associated with acute myocardial infarction risk in five ethnic groups: The INTERHEART genetics study Conferences
- Glucose levels predict incident cardiovascular events in a large international multiethnic cohort Conferences
- Household car and television ownership are associated with an increased risk of myocardial infarction: Results from the INTERHEART study Conferences
- Impact of PCI in patients with recent onset severe angina or stabilized ACS treated with optimal medical therapy: a COURAGE trial high risk subset Conferences
- Impact of optimal medical therapy with or without PCI on long-term cardiovascular endpoints in patients with stable coronary artery disease: Tertiary outcomes from the COURAGE trial Conferences
- Obesity metrics and their associations with type 2 diabetes and glucose levels in a large international multi-ethnic cohort Conferences
- Optimal medical therapy with or without percutaneous coronary intervention for stable coronary artery disease is effective in patients with chronic kidney disease Conferences
- Quality of life in COURAGE trial patients with diabetes Conferences
- Relationship between angiographic restenosis and clinical outcomes post-PCI in CAD patients: A pooled analysis of nine trials comparing drug-eluting vs. baremllilletal stents Conferences
- Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve) Conferences
- Strategy of intensive glycemic control with pioglitazone does not significantly reduce in-stent neointimal volume after percutaneous coronary intervention in type 2 diabetic patients Conferences
- The perioperative ischemic evaluation (POISE) trial: A randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery Conferences
- The relative safety and efficacy of clopidogrel in women and men: Meta-analysis of 79,613 patients enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA Conferences
- Work and leisure time related physical activity and the risk of myocardial infarction: Results of the INTERHEART study Conferences